Changing the Game Against Cancer – Time for New Thinking
The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
GlobalTort
- Feb 4, 2014
- 2 min
World Cancer Day 2014 – Data on New Cancers and Deaths
- Jan 1, 2014
- 1 min
Pro Bono Advocacy Opportunities for Persons with Cancer – Maybe a New Resolution for 2014?
- Dec 25, 2013
- 1 min
Honoring Others at Christmas – Cancer-related Giving
- Dec 23, 2013
- 1 min
Until Year End, 2x Match for Donations to Mesothelioma Research at MARF
- Dec 8, 2013
- 2 min
Reasons to Invest in Science – So Many Blood Cancers, and New Hope from Great New Science R
- Dec 2, 2013
- 10 min
Adoption of New MicroRNA Technology for Cancers
- Nov 20, 2013
- 1 min
Case Report on Simultaneous Lung Cancer and Localized Mesoethelioma
- Oct 15, 2013
- 1 min
Fall Out from Myriad – New Gene Patent Testing and Prices Are Starting to Fall
- Oct 10, 2013
- 2 min
AML, Lung Cancer, Benzene, Smoking and Epigenetics – More Evidence that Epigenetics Matters
- Sep 4, 2013
- 2 min
Wonder Drugs, and Sequencing Tumor Mutations
- Jul 31, 2013
- 3 min
An Impetus Towards More Benzene Litigation ? Higher Cancer Incidence in Persons Living Near Georgia
- Jul 31, 2013
- 1 min
Mryiad’s Arguments to Enjoin Some Entities Testing for BRCA Genes
- Jul 12, 2013
- 1 min
Good Words from a “Cancer Thriver”
- Jul 11, 2013
- 1 min
Gene Patent Battles Expand as Myriad Sues Again Over BRCA Genes
- Jul 10, 2013
- 1 min
The Gene Patent Wars Continue – Myriad Files Suit to Enjoin BRACA Testing
- Jul 2, 2013
- 4 min
Guidelines for Molecular Testing for Lung Cancers
- Jun 4, 2013
- 1 min
Cancer – The Emperor of All Maladies to Become a Six Hour Series on PBS
- Jun 3, 2013
- 1 min
New Phases in Treating Cancer – Economic Implications for Litigation and Otherwise
- May 29, 2013
- 5 min
How Much Should One Expect Lung Cancer Claiming to Increase Now that Low Dose CT Scans are Cheap and
About Kirk
Since becoming a lawyer in 1983, Kirk’s 35+ years of practice have focused on advising a wide range of corporations, associations, and individuals (as both plaintiffs and defendants) on both tort and commercial law issues centered around “mass torts.”